These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26806863)

  • 21. Low BDNF is associated with cognitive impairments in patients with Parkinson's disease.
    Wang Y; Liu H; Zhang BS; Soares JC; Zhang XY
    Parkinsonism Relat Disord; 2016 Aug; 29():66-71. PubMed ID: 27245919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
    Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
    Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BDNF 196 G/A and 270 C/T polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.
    Lee YH; Song GG
    J Mot Behav; 2014; 46(1):59-66. PubMed ID: 24329127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease.
    Ben Sassi S; Nabli F; Hentati E; Nahdi H; Trabelsi M; Ben Ayed H; Amouri R; Duda JE; Farrer MJ; Hentati F
    Parkinsonism Relat Disord; 2012 Mar; 18(3):243-6. PubMed ID: 22056842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive impairment in carriers of glucocerebrosidase gene mutation in Parkinson disease patients.
    Malec-Litwinowicz M; Rudzińska M; Szubiga M; Michalski M; Tomaszewski T; Szczudlik A
    Neurol Neurochir Pol; 2014; 48(4):258-61. PubMed ID: 25168325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of association between the BDNF Val66Met polymorphism and Parkinson's disease in a Swedish population.
    Håkansson A; Melke J; Westberg L; Shahabi HN; Buervenich S; Carmine A; Klingborg K; Grundell MB; Schulhof B; Holmberg B; Ahlberg J; Eriksson E; Sydow O; Olson L; Johnels B; Nissbrandt H
    Ann Neurol; 2003 Jun; 53(6):823. PubMed ID: 12783434
    [No Abstract]   [Full Text] [Related]  

  • 28. The Effects of BDNF Val66Met Gene Polymorphism on Serum BDNF and Cognitive Function in Methamphetamine-Dependent Patients and Normal Controls: A Case-Control Study.
    Su H; Tao J; Zhang J; Xie Y; Wang Y; Zhang Y; Han B; Lu Y; Sun H; Wei Y; Zou S; Wu W; Zhang J; Xu K; Zhang X; He J
    J Clin Psychopharmacol; 2015 Oct; 35(5):517-24. PubMed ID: 26280836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly.
    Miyajima F; Ollier W; Mayes A; Jackson A; Thacker N; Rabbitt P; Pendleton N; Horan M; Payton A
    Genes Brain Behav; 2008 Jun; 7(4):411-7. PubMed ID: 17973920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Met66 allele of the functional Val66Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemic lupus erythematosus.
    Oroszi G; Lapteva L; Davis E; Yarboro CH; Weickert T; Roebuck-Spencer T; Bleiberg J; Rosenstein D; Pao M; Lipsky PE; Goldman D; Lipsky RH; Illei GG
    Ann Rheum Dis; 2006 Oct; 65(10):1330-5. PubMed ID: 16606648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The genetic predictors of cognitive impairment in Parkinson's disease].
    Senkevich KA; Miliukhina IV; Pchelina SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(8):109-117. PubMed ID: 30251988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bdnf variant is associated with milder motor symptom severity in early-stage Parkinson's disease.
    Fischer DL; Auinger P; Goudreau JL; Paumier KL; Cole-Strauss A; Kemp CJ; Lipton JW; Sortwell CE
    Parkinsonism Relat Disord; 2018 Aug; 53():70-75. PubMed ID: 29759928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-Motor Symptoms after One Week of High Cadence Cycling in Parkinson's Disease.
    Harper SA; Dowdell BT; Kim JH; Pollock BS; Ridgel AL
    Int J Environ Res Public Health; 2019 Jun; 16(12):. PubMed ID: 31197095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [No effect of the BDNF Val66Met polymorphism on cognitive deficit in patients with schizophrenia and on the risk of the disease in their relatives].
    Alfimova MV; Golimbet VE; Korovaitseva GI; Lezheiko TV; Gabaeva MV; Oleichik IV; Stolyarov SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):75-79. PubMed ID: 25909793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of circulatory BDNF with cognitive deficits in people with Parkinson's disease.
    Khalil H; Alomari MA; Khabour OF; Al-Hieshan A; Bajwa JA
    J Neurol Sci; 2016 Mar; 362():217-20. PubMed ID: 26944151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical characteristics in Parkinson's disease patients with cognitive impairment and effects of cognitive impairment on sleep].
    Gong Y; Xiong KP; Mao CJ; Huang JY; Hu WD; Han F; Chen R; Liu CF
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2637-41. PubMed ID: 24360043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No association between the brain-derived neurotrophic factor 196 G>A or 270 C>T polymorphisms and Alzheimer's or Parkinson's disease.
    Saarela MS; Lehtimaki T; Rinne JO; Huhtala H; Rontu R; Hervonen A; Roytta M; Ahonen JP; Mattila KM
    Folia Neuropathol; 2006; 44(1):12-6. PubMed ID: 16565926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease.
    Foltynie T; Cheeran B; Williams-Gray CH; Edwards MJ; Schneider SA; Weinberger D; Rothwell JC; Barker RA; Bhatia KP
    J Neurol Neurosurg Psychiatry; 2009 Feb; 80(2):141-4. PubMed ID: 18977816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The brain-derived neurotrophic factor Val66Met polymorphism, hippocampal volume, and cognitive function in geriatric depression.
    Benjamin S; McQuoid DR; Potter GG; Payne ME; MacFall JR; Steffens DC; Taylor WD
    Am J Geriatr Psychiatry; 2010 Apr; 18(4):323-31. PubMed ID: 20220593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine receptors and BDNF-haplotypes predict dyskinesia in Parkinson's disease.
    Kusters CDJ; Paul KC; Guella I; Bronstein JM; Sinsheimer JS; Farrer MJ; Ritz BR
    Parkinsonism Relat Disord; 2018 Feb; 47():39-44. PubMed ID: 29191473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.